CEL001 Injection

CEL001 · Guangzhou Xiling Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEL001 Injection, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors [Phase 1]